InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
0.852
-0.047 (-5.22%)
At close: Apr 28, 2026, 4:00 PM EDT
0.867
+0.015 (1.73%)
After-hours: Apr 28, 2026, 4:10 PM EDT
InterCure Employees
InterCure had 320 employees as of December 31, 2024. The number of employees increased by 50 or 18.52% compared to the previous year.
Employees
320
Change (1Y)
50
Growth (1Y)
18.52%
Revenue / Employee
$225,495
Profits / Employee
-$65,789
Market Cap
50.25M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Zhengye Biotechnology Holding | 277 |
| China Pharma Holdings | 215 |
| Rockwell Medical | 157 |
| Cumberland Pharmaceuticals | 93 |
| Aytu BioPharma | 83 |
| BioXcel Therapeutics | 29 |
| SCYNEXIS | 18 |
| Incannex Healthcare | 12 |
INCR News
- 7 weeks ago - InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement - GlobeNewsWire
- 2 months ago - InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million - GlobeNewsWire
- 6 months ago - InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements to Advance Cannabis Science and Pharmaceutical Innovation - GlobeNewsWire
- 7 months ago - InterCure Reports First Half 2025 Results with NIS 130 Million in Revenue and Positive Operating Cash Flow - GlobeNewsWire
- 7 months ago - InterCure Announces Strategic Acquisition of ISHI, Unlocking Access to Premium U.S. Cannabis Technology and Brands - GlobeNewsWire
- 1 year ago - InterCure Announces FY2024 Results and Provides Q1 2025 Update: Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million, Strong Start to 2025 - PRNewsWire
- 1 year ago - InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak - PRNewsWire
- 1 year ago - InterCure has Secured Funding of NIS 66M to support the recovery of Nir Oz Facility - PRNewsWire